SYRS vs REGN: Which Stock is Better?
Side-by-side comparison of Syros Pharmaceuticals Inc and Regeneron Pharmaceuticals Inc in 2026
SYRS
Syros Pharmaceuticals Inc
—
REGN
Regeneron Pharmaceuticals Inc
$654.27
Key Metrics Comparison
| Metric | SYRS | REGN | Winner |
|---|---|---|---|
| Market Cap | $0.01M | $59.10B | REGN |
| P/E Ratio | N/A | 13.91 | REGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze SYRS
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is SYRS or REGN a better investment?
Comparing SYRS and REGN: Syros Pharmaceuticals Inc has a market cap of $0.01M while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between SYRS and REGN?
SYRS (Syros Pharmaceuticals Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: SYRS or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: SYRS or REGN?
Both SYRS and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: SYRS or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: SYRS or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $0.01M for SYRS.
Should I buy SYRS or REGN in 2026?
Both SYRS and REGN have investment merit. SYRS trades at $N/A while REGN trades at $654.27. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between SYRS and REGN stock?
Key differences: Market Cap ($0.01M vs $59.10B), P/E Ratio (N/A vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy SYRS or REGN in 2026?
The choice between SYRS and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between SYRS and REGN?
SYRS (Syros Pharmaceuticals Inc) has a market cap of $0.01M, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.